ERNA vs IR · P/E 0.0, rev $582.0K vs P/E 49, rev $7.24B
Eterna Therapeutics Inc (ERNA) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the ERNA and IR stock pages for the full models.
Not investment advice.